The CDX also expresses a neuroendocrine phenotype positive for synaptophysin, chromogranin, NSE, and absence of PSA and AR, and reflects the functional state of neuroendocrine prostate carcinoma in being unresponsive to androgen deprivation. Here, ENO2 is linked to prostate neuroendocrine neoplasm.